News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
TANG CAPITAL PARTNERS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 11% stake in ASLAN Pharmaceuticals Limited |
| 05/05/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Corvus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 5.3% stake in CytomX Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 3.2% stake in Heron Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Inspirato Incorporated |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 9.4% stake in KalVista Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 10% stake in Metacrine, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 9.9% stake in Pyxis Oncology, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 10% stake in Reviva Pharmaceuticals Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.5% stake in Tarsus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.1% stake in TCR2 Therapeutics Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 2% stake in Albireo Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.8% stake in ASLAN Pharmaceuticals Limited |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 8.6% stake in BioAtla, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 5.6% stake in bluebird bio, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.4% stake in Tonix Pharmaceuticals Holding Corp. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.1% stake in Aligos Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 5.5% stake in Altimmune, Inc. |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Veru, Inc. |
| 02/14/2022 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 4% stake in aTyr Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 4.9% stake in Vincerx Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 3.9% stake in Rocket Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 6.7% stake in Corvus Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.8% stake in Heron Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 8.9% stake in Relmada Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in Cellectar Biosciences, Inc. |
| 02/14/2020 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 7.9% stake in Evolus, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/15/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|